Form 8-K - Current report:
SEC Accession No. 0001437749-24-031957
Filing Date
2024-10-24
Accepted
2024-10-24 07:00:40
Documents
18
Period of Report
2024-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20241021_8k.htm   iXBRL 8-K 60995
2 LICENSE AGREEMENT BETWEEN ALEXION AND MONOPAR DATED AS OF OCTOBER XX, 2024 ex_735036.htm EX-10.1 427373
3 COMMON STOCK INVESTMENT AGREEMENT BETWEEN ALEXION AND MONOPAR DATED AS OF OCTOBE ex_735037.htm EX-10.2 106585
4 EXHIBIT 99.1 ex_735003.htm EX-99.1 16654
9 monologo.jpg GRAPHIC 3641
  Complete submission text file 0001437749-24-031957.txt   872029

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20241023.xsd EX-101.SCH 3410
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20241023_def.xml EX-101.DEF 12188
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20241023_lab.xml EX-101.LAB 16397
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20241023_pre.xml EX-101.PRE 12458
20 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20241021_8k_htm.xml XML 3058
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 241390681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)